Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 12:42 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1849–1872 of 13,940 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Trial Clear all

Conditions: Prevention of Hair Growth
Interventions: 1% topical cidofovir, 3% topical cidofovir, Placebo; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older · Male only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Vesicoureteral Reflux, Urinary Tract Infections
Interventions: Trimethoprim-Sulfamethoxazole, Placebo; Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 2 Months to 71 Months
Enrollment: 607 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2014
U.S. locations: 19
States / cities: Birmingham, Alabama • Wilmington, Delaware • Washington D.C., District of Columbia + 16 more

Conditions: HIV
Interventions: Post test video; Behavioral
Lead sponsor: North Bronx Healthcare Network; Other
Eligibility: 18 Years and older
Enrollment: 128 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Amyotrophic Lateral Sclerosis (ALS)
Interventions: rasagiline; Drug
Lead sponsor: Yunxia Wang, MD; Other
Eligibility: 21 Years to 80 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 9
States / cities: Phoenix, Arizona • San Francisco, California • Iowa City, Iowa + 6 more

Conditions: Obesity
Interventions: StomaphyX, Sham procedure; Device · Procedure
Lead sponsor: EndoGastric Solutions; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 2
States / cities: Columbus, Ohio • Pittsburgh, Pennsylvania

Conditions: Severe COVID-19 Disease
Interventions: RAPA-501-Allo off-the-shelf Therapy of COVID-19, Placebo; Biological · Other
Lead sponsor: Rapa Therapeutics LLC; Industry
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Hackensack, New Jersey

Conditions: Plaque, Gingivitis
Interventions: 2 mg KSL-W, 4 mg KSL-W, 6 mg KSL-W, 10 mg KSL-W, 20 mg KSL-W, 30 mg KSL-W, 50 mg KSL-W, 75 mg KSL-W, 100 mg KSL-W, Placebo; Drug · Other
Lead sponsor: U.S. Army Medical Research and Development Command; Federal
Eligibility: 18 Years to 64 Years
Enrollment: 135 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Diet, Food, and Nutrition, Accidental Fall, Diabetes Mellitus, Heart Diseases
Interventions: Meals + RD services only, Meals + OT services only, Meals + RD + OT services; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 60 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Drug Use Disorders, Illicit Drug Use, Alcohol-Related Disorders, Opioid Use Disorder
Interventions: Standard implementation, Health Coaching, Practice Facilitation; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older
Enrollment: 18,430 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Schizophrenia, Schizoaffective Disorder
Interventions: Valacyclovir, Placebo; Drug
Lead sponsor: Konasale Prasad; Other
Eligibility: 18 Years to 50 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2016
U.S. locations: 2
States / cities: Detroit, Michigan • Pittsburgh, Pennsylvania

Conditions: Obesity, Maternal, Pre-Eclampsia; Complicating Pregnancy, Gestational Hypertension, Eclampsia; Complicating Pregnancy
Interventions: MFeast ENHANCED, MFeast Usual Care; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Ventral Hernia
Interventions: laparoscopic repair, robot-assisted repair; Procedure
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 99 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Mechanical Low Back Pain
Interventions: Patient Decision Making tool, Standard of care; Behavioral · Other
Lead sponsor: Walsh University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Greenville, South Carolina

Conditions: Cyclic Vomiting Syndrome
Interventions: Active percutaneous electrical nerve field stimulation, Sham percutaneous electrical nerve field stimulation; Device
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 5 Years to 18 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Essential Hypertension
Interventions: Allopurinol, Placebo; Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 12 Years to 18 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Pseudobulbar Affect (PBA)
Interventions: dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg, dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg, Placebo; Drug
Lead sponsor: Avanir Pharmaceuticals; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 326 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 45
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Anaheim, California + 39 more

Conditions: Hypoparathyroidism
Interventions: MBX 2109, Placebo; Drug · Other
Lead sponsor: MBX Biosciences; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 27
States / cities: Sacramento, California • Jacksonville, Florida • Miami, Florida + 22 more

Conditions: Hypertension
Interventions: Positive Affect/Self-Affirmation/Motivational Interviewing, Educational and Behavioral; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 238 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Posttraumatic Stress Disorder, Cancer
Interventions: Cancer Distress Coach Mobile App; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 569 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Complex Obstetric Surgery, Perioperative Pain Management, Cesarean Delivery, Postoperative Pain Control
Interventions: Bupivicaine intervention arm, Placebo arm; Drug
Lead sponsor: University of Tennessee; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Knee Osteoarthritis
Interventions: Vitamin D, Control; Drug
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 137 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Fatty Liver
Interventions: Glucophage (Metformin), Placebo; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Coronary Heart Disease, Cardiovascular Disease
Interventions: Transcendental Meditation, Health Education; Behavioral
Lead sponsor: Maharishi International University; Other
Eligibility: Not listed
Enrollment: 201 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2007
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Hepatitis C
Interventions: Rifaximin, Placebo; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Trial of Topical Cidofovir for the Prevention of Hair Growth

Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR)

A Theory Based HIV Prevention Video For Rapid HIV Testing: A Randomized Trial

Trial of Safety and Efficacy of Rasagiline in Patients With Amyotrophic Lateral Sclerosis (ALS)

StomaphyX Versus Sham for Revisional Surgery in Post-Roux-en-Y Patients to Reduce Regained Weight

RAPA-501-Allo Therapy of COVID-19-ARDS

Safety and Tolerability of Antiplaque Chewing Gum in a Gingivitis Population

Tailoring OT and RD Services for Home-delivered Meal Clients

Digital Treatments for Opioids and Other Substance Use Disorders in Primary Care

Systematic Evaluation of Antiviral Medication in Schizophrenia

Nutrition Optimization and Community Upliftment for Postpartum Recovery: Hypertension

Laparoscopic Versus Robot-assisted Ventral Hernia Repair: a Single Institution Randomized Controlled Trial

Influence of Patient-Informed Choice in a Novel Treatment Model for LBP

A Study of Auricular Neurostimulation for Children With Cyclic Vomiting Syndrome

Uric Acid in Essential Hypertension in Children

Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS

Safety, Pharmacokinetics and Efficacy of MBX 2109 in Patients With Hypoparathyroidism

Trial Using Motivational Interviewing Positive Affect and Self-Affirmation in Hypertension (TRIUMPH)

Cancer Distress Coach Mobile App Trial

COMFORT Trial: Complex Obstetric Management With Focused Regional Transversus Abdominis Plane Block

Evaluating Vitamin D3 Supplement on Post-Op Outcomes

Metformin for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)

A Randomized Controlled Trial of Stress Reduction on Cardiovascular Morbidity and Mortality in African Americans

Rifaximin to Prevent Recurrent HCV-Related Fibrosis After Liver Transplant